Skip to main content

Address And Details

Guggenheim Investments, P.O. Box 758567 , Topeka, KS 66675
Fund Manager Michael P. Byrum
Manager Tenure 16 Years 11 Months

Strategy And Objective

The Biotechnology Fund (the Fund) seeks to provide capital appreciation by investing in companies that are involved in the biotechnology industry,including companies involved in research and development, genetic or other biological engineering, and in the design, manufacture, or sale of related biotechnology products or services (Biotechnology Companies). Under normal circumstances, the Fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. The Advisor employs a proprietary quantitative and qualitative methodology to identify Biotechnology Companies in which to invest. The methodology utilizes screens based on price, liquidity, and tradability. Stocks are weighted using a proprietary modified capitalization weighting methodology. The portfolio may be further adjusted to comply with regulatory investment limitations or as determined appropriate by the Advisor.

Net Asset Value

as of 5:40 PM ET 05/20/2022

Performance

  • 1 Week
  • +2.27%
  • 1 Month
  • -9.81%
  • 3 Months
  • -6.24%
  • 1 Yr Return
  • -32.52%
  • 5 Yr Return
  • -22.72%

Equity Sector Breakdown

Health 66.12%
Services 14.84%
Technology 4.25%
NonDurables 2.63%
IndustrialCyclical 0.88%
ConsumerDurables n/a
Energy n/a
Finance n/a
RetailTrade n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 99.31%
ForeignStocks 2.19%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 17.25 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -5.97 -5.92 -1.10
Beta 0.82 0.92 1.05
R Squared 0.50 0.51 0.40
Std Deviation 21.72 21.38 22.69
Sharpe Ratio 0.25 0.29 n/a

Purchase Information

as of 5:38 PM ET 05/19/2022
Minimum Initial $2500
Minimum Additional $0
Minimum Initial IRA $1000

Performance

Timeframe Average Annual Current Performance Monthly As Of 04/30/2022 Average Annual Current Performance Quarterly As Of 03/31/2022 Avg Annual Current Performance Monthly As Of 04/30/2022 Avg Annual Current Performance Quarterly As Of 03/31/2022
1 Year
  • -19.76%
  • -7.04%
-19.76% -7.04%
3 Year
  • +3.82%
  • +5.47%
+3.82% +5.47%
10 Year
  • +11.27%
  • +12.58%
+11.27% +12.58%
Life Of Fund
  • +10.40%
  • +11.11%
+10.40% +11.11%

Top 10 Holdings

Symbol Company Name % Of Assets
ABBV ABBVIE INC 6.95%
AMGN AMGEN INC 4.91%
MRNA MODERNA INC 4.26%
GILD GILEAD SCIENCES INC 4.22%
REGN REGENERON PHARMACEUTICALS 3.66%
CASH TOTAL*MONEY MARKET 3.49%
VRTX VERTEX PHARMACEUTICALS INC 3.36%
ILMN ILLUMINA INC 3.33%
CTVA CORTEVA INC 2.63%
BGEN BIOGEN INC 2.61%

Recommended for You